Thematics Asset Management Grows Position in UnitedHealth Group Incorporated $UNH

Key Points

• Thematics Asset Management increased its stake in UnitedHealth Group by 17.7%, now holding 12,218 shares worth approximately $6.4 million.
• Several major investors have significantly raised their positions in UnitedHealth, including GAMMA Investing LLC with a 56,142.1% increase, owning over $4.34 billion in shares.
• UnitedHealth's recent earnings report showed a miss on consensus EPS estimates at $4.08, alongside a revenue of $111.62 billion, which was slightly below expectations.

Thematics Asset Management increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,218 shares of the healthcare conglomerate's stock after buying an additional 1,840 shares during the period. Thematics Asset Management's holdings in UnitedHealth Group were worth $6,399,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in UNH. GAMMA Investing LLC increased its stake in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the period. Nuveen LLC purchased a new position in UnitedHealth Group in the first quarter valued at approximately $3,846,764,000. Vanguard Group Inc. increased its stake in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP increased its stake in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have commented on UNH. Royal Bank Of Canada dropped their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. HSBC reissued a "reduce" rating and issued a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. KeyCorp decreased their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Finally, JPMorgan Chase & Co. decreased their price target on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $365.38.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Up 1.2%

UnitedHealth Group stock opened at $307.0980 on Friday. The stock has a market cap of $278.13 billion, a PE ratio of 13.31, a P/E/G ratio of 1.98 and a beta of 0.43. The stock has a 50-day moving average price of $288.39 and a 200 day moving average price of $388.53. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the company earned $6.80 EPS. The company's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.